Gaddie I B, Bennett D W
Department of Optometry, Northeastern State University, College of Optometry, Tahlequah, Oklahoma, USA.
J Am Optom Assoc. 1998 Feb;69(2):122-8.
Cystoid macular edema is a common clinical finding following intraocular surgery. Certain medications have been associated with an increased incidence of cystoid macular edema. This article describes the clinical findings in two eyes of two patients in whom cystoid macular edema developed directly following treatment with the anti-glaucoma medication latanoprost, and assesses the possible causal relationship.
Clinical correlative and angiographic studies of two patients in a referral practice are presented. The main outcome measurement was visual acuity and fundus examination on discontinuation of latanoprost.
Cystoid macular edema developed in two pseudophakic patients after the use of latanoprost.
Latanoprost should be used with caution in pseudophakic and aphakic patients--especially those with retinal vascular fragility, any inflammatory uveal disease, or other factors that may predispose to the breakdown of the blood-retinal barrier.
黄斑囊样水肿是眼内手术后常见的临床症状。某些药物与黄斑囊样水肿发病率的增加有关。本文描述了两名患者的双眼在使用抗青光眼药物拉坦前列素治疗后直接发生黄斑囊样水肿的临床症状，并评估了可能的因果关系。
介绍了在转诊诊所对两名患者进行的临床相关及血管造影研究。主要观察指标为停用拉坦前列素后的视力和眼底检查。
两名人工晶状体植入患者在使用拉坦前列素后发生了黄斑囊样水肿。
在人工晶状体植入和无晶状体患者中应谨慎使用拉坦前列素——尤其是那些有视网膜血管脆弱性、任何炎症性葡萄膜疾病或其他可能易导致血视网膜屏障破坏的因素的患者。
